A. Couturier

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes

Julio Rosenstock, S. W Kim, Michelle A. Baron et al. · Diabetes Obesity and Metabolism · 2007 · 258 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Comparison between vildagliptin and metformin to sustain reductions in HbA_1c over 1 year in drug‐naïve patients with Type 2 diabetes

Anja Schweizer, A. Couturier, James E. Foley et al. · Diabetic Medicine · 2007 · 239 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea*

A. J. Garber, James E. Foley, Mary Ann Banerji et al. · Diabetes Obesity and Metabolism · 2008 · 233 citations

Medicine, Pharmacology, Pharmacotherapy +17

Vildagliptin add‐on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2‐year study

David R. Matthews, S. Dejager, Bo Åhrén et al. · Diabetes Obesity and Metabolism · 2010 · 199 citations

Medicine, Pharmacology, Pharmacotherapy +11

An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials

Monica Ligueros‐Saylan, James E. Foley, Anja Schweizer et al. · Diabetes Obesity and Metabolism · 2010 · 145 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11